HomeTLIS • NASDAQ
add
Talis Biomedical Corp
Previous close
$9.05
Day range
$8.77 - $9.20
Year range
$4.35 - $9.32
Market cap
16.76M USD
Avg Volume
8.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 195.00K | -24.12% |
Operating expense | -25.31M | 46.52% |
Net income | -13.46M | 50.02% |
Net profit margin | -6.90K | 34.12% |
Earnings per share | — | — |
EBITDA | -14.24M | 32.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 76.73M | -41.06% |
Total assets | 94.67M | -44.08% |
Total liabilities | 25.56M | -39.94% |
Total equity | 69.12M | — |
Shares outstanding | 1.82M | — |
Price to book | 0.24 | — |
Return on assets | -35.80% | — |
Return on capital | -37.96% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.46M | 50.02% |
Cash from operations | -11.36M | 16.14% |
Cash from investing | 93.00K | 289.80% |
Cash from financing | 0.00 | — |
Net change in cash | -11.26M | 17.13% |
Free cash flow | -6.82M | -5.96% |
About
Founded
2013
Headquarters
Website
Employees
99